New estimates show Medicare Advantage is costing far more than expected, prompting a federal crackdown. The changes could ...

The S&P 500 barely managed a record closing high on Tuesday, its fifth straight day of gains with investor optimism ahead of megacap earnings reports being countered by a mixed reception to the latest ...

Major indcies were little changed at the close of trading on Wednesday as investors digested the Federal Reserve's decision ...

Over the past week, health insurers have drawn the ire of lawmakers on both sides of the aisle and seen their collective stock prices drop by nearly $100 billion following unfavorable Medicare ...

The S&P 500 briefly surpassed the 7,000 threshold during Wednesday's session, but ultimately ended the day near flat.

Jan. 27 produced something one rarely sees in the stock market. One stock fell so hard that its loss caused the Dow Jones Industrial Average to fall about 409 points, or 0.8%, to 49,003. The culprit ...

UNH earnings reveal rising margin pressure from Medicare Advantage; investors may look to these healthcare ETFs for ...

We recently published 10 Big Names With Painful Declines. Humana Inc. (NYSE:HUM) was one of the worst performers on Tuesday.

Healthcare Investors is rated a Buy due to solid fundamentals and a strong distribution. Learn more about HQH stock here.

Major equities indexes advanced Wednesday, with the S&P 500 crossing the 7000 level for the first time, ahead of the Federal ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

Humana stock plunged 21% after a shockingly low Medicare Advantage rate proposal threatens margins and clouds the insurer’s ...